tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O

OncoTherapy Science (30O) Revenue

Compare
0 Followers

OncoTherapy Science Revenue

OncoTherapy Science had a revenue of 338.00M in the quarter ending Dec 31, 2024, with 170.40%. This bring the company's revenue in the last twelve months to 707.11M, Decreased 47.73%. In the fiscal year ending Mar 31, 2025, OncoTherapy Science had annual revenue of 750.05M with 22.93% growth.
Revenue (ttm)
707.11M
Revenue Growth
P/S Ratio
0.05
Revenue/Employee
€13,889,778
Employees
54
Market Cap
€34.76M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
750.05M139.93M+22.93%
Mar 31, 2024
610.12M-524.78M-46.24%
Mar 31, 2023
1.13B-18.76M-1.63%
Mar 31, 2022
1.15B821.19M+246.99%
Mar 31, 2021
332.48M16.26M+5.14%
Mar 31, 2020
316.21M35.63M+12.70%
Mar 31, 2019
280.59M69.33M+32.82%
Mar 31, 2018
211.25M-75.42M-26.31%
Mar 31, 2017
286.67M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis